"Reprogramming of differentiated human cells was accomplished in 2007 and early 2008 [37–40]. This was soon followed by generation of iPS [induced pluripotent stem] cells from patients with various diseases such as amyotrophic lateral sclerosis [41], adenosine deaminase deficiency related SCID, Parkinson’s disease and Down’s syndrome[42], and this is of considerable importance to begin to dissect the disease process in vitro." Complete Abstract
This article gives an overview of the history of regenerative medicine and how far we have come in regards to the research/use of embryonic stem stem cells to treat various conditions. Since 2007, induced pluripotent stem cells have been extracted from patients with a range of different diseases. It is suggested that the use of these cells, which have proved their ability to differentiate, could be groundbreaking in the treatment/cure of numerous diseases. The next step in allowing this to happen is the Patients First Act of 2009. This bill can be the change.
Andersson, E. R., & Lendahl, U. (2009). Regenerative medicine: A 2009 overview. Journal of Internal Medicine, 266(4), 303-310. doi:10.1111/j.1365-2796.2009.02157.x
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment